Precision Biologics
Signal active
Organization
Contact Information
Overview
Precision Biologics is a clinical stage biotechnology corporation focused on developing therapeutic and diagnostic products for the early detection and treatment of cancer. The company’s antibody drug candidates and diagnostics are designed to detect and target the tumor without destroying healthy cells. Precision Biologics is uniquely positioned to create innovative therapeutics through the use of proprietary cancer vaccines, several of which have demonstrated success in human trials.
About
Industries
Biotechnology, Health Care, Therapeutics, Health Diagnostics
Founded
2012
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Precision Biologics headquartered in United States, North America, operates in the Biotechnology, Health Care, Therapeutics, Health Diagnostics sector. The company focuses on Biotechnology and has secured $3.8B in funding across 64 round(s). With a team of 11-50 employees, Precision Biologics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Precision Biologics, raised $795.0K. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
4
Investors
0
Lead Investors
0
Total Funding Amount
$59.4M
Details
1
Precision Biologics has raised a total of $59.4M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2012 | Seed | 5.3M |
Investors
Precision Biologics is funded by 2 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Precision Biologics | - | FUNDING ROUND - Precision Biologics | 50.0M |
| NantWorks | - | FUNDING ROUND - NantWorks | 50.0M |
Recent Activity
There is no recent news or activity for this profile.